Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
The Addition of Amphetamine to Potentially Sedating Medication Regimens: An Exploratory Investigation of the Impact upon Reaction Time and Sustained Attention
1
x
$
30.00
Single Dose and Repeat Once-Daily Dose Safety, Tolerability and Pharmacokinetics of Valbenazine in Healthy Male Subjects
1
x
$
0.00
Schizophrenia and Valproate
1
x
$
30.00
Monoarthritis Induced by Bupropion Hydrochloride by Barry N. Williams
1
x
$
30.00
Clozapine Related Suicidal Obsession by Branka Aukst-Margetic
1
x
$
30.00
Test of Treatment in Psychiatric Practice by Feras Ali Mustafa
1
x
$
30.00
Clozapine Factors in Schizophrenia by Takefumi Suzuki
1
x
$
30.00
View Cart
Checkout
Home
Gregor E. Berger, MD, FMH Psych (CH): Incipient Neurovulnerability and Neuroprotection in Early Psychosis
“Clozapine Factors in Schizophrenia by Takefumi Suzuki” has been added to your cart.
View cart
Gregor E. Berger, MD, FMH Psych (CH): Incipient Neurovulnerability and Neuroprotection in Early Psychosis
$
30.00
Gregor E. Berger, MD, FMH Psych (CH): Incipient Neurovulnerability and Neuroprotection in Early Psychosis quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 37 No. 2 Articles
Tags:
apoptosis
,
delete-regulation
,
early-intervention
,
early-psychosis
,
first-episode-psychosis
,
fmh-psych-ch
,
franzcp
,
frcp
,
glia
,
gregor-e-berger
,
mbbs
,
medworks-media
,
neurodegeneration
,
neurodevelopment
,
neurogenesis
,
neuroprotection
,
patrick-d-mcgorry
,
prodromal
,
progenitor-cells
,
psychopharmacology-bulletin
,
regulation
,
schizophrenia
,
stephen-wood
,
treatment
Description
Description
Gregor E. Berger, MD, FMH Psych (CH)
TRANSLATIONAL NEUROSCIENCE
Incipient Neurovulnerability and Neuroprotection in Early Psychosis
Gregor E. Berger, MD, FMH Psych (CH), Stephen Wood, MA (Cantab), PhD, and Patrick D. McGorry, MBBS, MD, PhD, FRCP, FRANZCP
Related products
Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas
$
30.00
Add to cart
Details
Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3
$
30.00
Add to cart
Details
Schizophrenia Rating Scales Critical Review by Takefumi Suzuki
$
30.00
Add to cart
Details
Monoarthritis Induced by Bupropion Hydrochloride by Barry N. Williams
$
30.00
Add to cart
Details
Page load link
Go to Top
